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Mouse pancreas has a remarkable ability to regenerate after partial pancreatectomy, and several investigators have
studied the underlying mechanisms involved in this regeneration process; however, the field remains contentious.
Elegant lineage-tracing studies undertaken over a decade have generated strong evidence against neogenesis from
stem cells and in favor of reduplication of pre-existing islets. Ductal epithelium has also been implicated during
regeneration. We recently provided direct evidence for the possible involvement of very small embryonic-like stem
cells (VSELs) during regeneration after partial pancreatectomy in mice. VSELs were first reported in pancreas in 2008
and are mobilized in large numbers after treating mice with streptozotocin and in patients with pancreatic cancer.
VSELs can be detected in mouse pancreas as small-sized LIN−/CD45−/SCA-1+ cells (3 to 5 μm), present in small
numbers (0.6%), which express nuclear Oct-4 (octamer-binding transcription factor 4) and other pluripotent markers
along with their immediate descendant ‘progenitors’, which are slightly bigger and co-express Oct-4 and PDX-1.
VSELs and the progenitors get mobilized in large numbers after partial pancreatectomy and regenerate both pancreatic
islets and acinar cells. In this review, we deliberate upon possible reasons why VSELs have eluded scientists so far.
Because of their small size, VSELs are probably unknowingly and inadvertently discarded during processing. Similar to
menopause and related loss of ovarian function, type 2 diabetes mellitus occurs because of a decline in beta-cell
function possibly resulting from an age-related compromised niche which does not allow VSELs to maintain normal
homeostasis. As suggested earlier for ovarian cancers, the presence of Oct-4 and other pluripotent markers in
pancreatic cancers is suggestive of VSELs as the possible cancer-initiating stem cells. Several issues raised in the
review require urgent confirmation and thus provide scope for further research before arriving at a consensus on
the fundamental role played by VSELs in normal pancreas biology and during regeneration, aging, and cancer. In
the future, such understanding may allow manipulation of endogenous VSELs to our advantage in patients with
diabetes and also to treat cancer.Introduction
The pancreas is one of three organs (besides lung and
liver) with huge regenerative ability. However, the mech-
anism underlying this remarkable regeneration is still
shrouded in controversy and was recently reviewed [1,2].
Views are divided as to whether regeneration involves
stem cells or is a mere reduplication of pre-existing islets
and also whether the number of islets is fixed by birth or
they are replenished possibly by the ductal epithelial (DE)
cells. Understanding the basic mechanism responsible for* Correspondence: deepa.bhartiya@yahoo.in
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volved has lot of relevance given the huge global burden
of diabetes.
We recently demonstrated a role of very small
embryonic-like stem cells (VSELs) in mouse pancreas re-
generation after partial pancreatectomy [3], in agreement
with earlier studies reporting the presence of VSELs in
adult pancreas [4] and their mobilization in response to
streptozotocin treatment [5]. However, a careful review
of the literature reveals that a study by Xiao and col-
leagues [6] seems to have sealed the controversy about
pancreas regeneration. Their results demonstrate that
stem cells have no role during regeneration and firmlyntral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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duplication of existing islets [7] and are in agreement
with the conclusions drawn by Teta and colleagues [8]
that label-retaining stem cells do not exist in pancreas.
These studies have also contradicted the concept pro-
posed by Bonner-Weir and Sharma [9] that DE cells
may have a role during regeneration of pancreas.
Our results that VSELs may have a role in pancreatic
regeneration [3] may be disregarded with time and die a
slow death because of the prevailing views in the field of
pancreas biology and also because the very existence of
VSELs is riddled with controversy [10]. This review is
our humble attempt to make a strong case for VSELs
during pancreas regeneration, aging, and carcinogenesis
and to point out technical reasons that may explain why
the pancreatic VSELs have eluded the scientific commu-
nity until now.
An introduction to very small embryonic-like stem cells
Readers may refer to recent publications to under-
stand VSEL biology [11-14]. In brief, VSELs are small
(3- to 5-μm) cells which can be enriched by flow cy-
tometry as LIN−/CD45−/SCA+ cells in mice and as
LIN−/CD45−/CD133+ cells in humans. It is suggested
that, during early embryonic development, pluripotent
primordial germ cells (PGCs) migrate to various develop-
ing organs, including the gonads, and survive as VSELs
throughout life and serve as a backup pool for tissue-
specific progenitors to maintain normal steady-state, are
mobilized in response to injury to various organs, and are
possibly the embryonic remnants resulting in cancer dur-
ing adult life [15-17]. They express various pluripotent as
well as PGC-specific markers and are relatively quiescent
[18,19]. VSELs give rise to cells of all three germ layers in
mice [20] and also in humans [21]. However, unlike pluri-
potent embryonic stem cells (ESCs), VSELs neither form
teratoma in severe combined immunodeficiency mice nor
complement a developing embryo. The mechanisms
underlying their pluripotent [19] and quiescent [22,23]
states have been well studied.
The very existence of VSELs was recently debated
[10], and the reasons resulting in the controversy were
explained [14]. Our group has focused on VSEL biology
in adult testes and ovaries [24,25]. Recently, we made a
case for VSELs to explain adult ovarian biology, failure,
menopause, and cancer [26,27]. Besides the role of
VSELs during pancreatic regeneration [3], bone marrow
VSELs have recently been implicated during hepatic re-
generation [28] and their vasculogenic potential has been
demonstrated in patients with critical leg ischemia [29].
Does Oct-4 have a role in somatic tissues?
The spurt of publications reporting the presence of Oct-4
(octamer-binding transcription factor 4) gene expressionin somatic organs and cancers (Table S1 in [30]) was a
cause of concern to Schöler, Jaenisch, and their group.
Oct-4 is a marker for pluripotent stem cells and is ex-
pected to be expressed in ESCs and PGCs and not in som-
atic tissues [31]. The group provided strong ‘ironclad’
evidence that OCT-4 has no role in adult organ homeosta-
sis. They used a strain of mice in which the endogenous
Oct-4 locus was targeted by lox P sites, when crossed with
various strains with tissue-specific Cre recombinase, and
was selectively deleted in specific organs to enable the
study of organ function in the absence of Oct-4. They ob-
served that ablating Oct-4 in various somatic tissues (skin,
liver, and bone marrow) had no effect on tissue homeosta-
sis or regeneration and thus concluded that Oct-4 has
minimal effect in somatic stem cells. Berg and Goodell
[32] wrote a commentary on this work and cautioned that
absence of evidence is not evidence for absence. Also, they
suggested that transgenic Cre recombinase possibly was
expressed not in the true stem cells but only in the
progenitors.
We agree with the thought process of Berg and Goodell
[32], and it is likely that in the study by Lengner and col-
leagues [30], transgenic Cre recombinase may not have
been expressed in the VSELs. Alternatively, when both
VSELs and tissue-specific progenitors were deleted by the
approach used by Lengner and colleagues [30], normal
VSELs were mobilized from the bone marrow in response
to the induced stress and brought about homeostasis. Fur-
ther studies are required in this study model to help de-
cipher the role of Oct-4 expressing VSELs in adult
somatic tissues and cancers.
The role of very small embryonic-like stem cells during
pancreas regeneration
Melton’s group proposed that pancreas regeneration oc-
curs by reduplication of pre-existing islets and that there
is no role of stem cells in the process. The study by Dor
and colleagues [7] had associated technical issues and
was discussed [9]. A careful examination of the methods
shows that five injections of tamoxifen (4 mg, intra-
peritoneal or subcutaneous twice a week) were given
over a period of more than 15 days and resulted in nu-
clear translocation of Cre estrogen receptor protein,
allowing expression of human placental alkaline phos-
phatase (HPAP) in insulin-expressing cells and their pro-
geny. But during this time, VSELs (expected to harbor
the transgene) could also have differentiated into HPAP-
expressing beta cells. Thus, it is possible that, rather
than a reduplication of pre-existing islets, the new islets
possibly regenerated from pluripotent VSELs in agree-
ment with our findings [3].
Rather than using the controversial Cre system for
lineage tracing, Teta and colleagues [8] used thymidine
analog incorporation and found no signs of label-
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regeneration, thus confirming the earlier findings of Dor
and colleagues [7]. However, if their results are com-
pared with our published results [3], it is apparent that
they were focusing only on the islets to find label-
retaining cells but we show that stem cells/progenitors
occur at other distinct locations (besides the islets). Islets
comprise an actively dividing and differentiating cell
population (not a stem cell population) where the label
may have been washed off.
Bonner-Weir’s group [33] proposed that pancreas re-
generation involves DE cells which undergo de-
differentiation and differentiate into islets and acinar
cells. Three groups [34-36] carried out lineage-tracing
studies using different DE-specific markers to investigate
whether ductal cells could be the source of new beta
cells and resulted in inconsistent data. Whereas Bonner-
Weir’s group found direct evidence in support of neo-
genesis by using carbonic anhydrase II promoter as the
marker for lineage tracing, others, using Sox-9 and Hnf,
failed to support these results. This controversy was dis-
cussed [37], and we propose that the use of markers like
Sca-1, Nanog, Sox-2, or Oct-4 for lineage tracing will
provide more meaningful results.
Xiao and colleagues [6] provided strong evidence to
support earlier views of Melton’s group that pancreas re-
generation does not involve stem cells. The group used a
tamoxifen-free technique wherein they employed a dual
reporter system in which expression of Cre recombin-
ase driven by the insulin promoter causes the deletion
of a red fluorescent reporter and simultaneously acti-
vates a green fluorescent reporter. If a red non-beta cell
differentiated into a beta cell (neogenesis), it would
turn on the insulin gene and Cre recombinase. For a
brief period, the overlap of red and green fluorescence
would produce a yellow signal until the red fluorescent
protein degrades and the cell turns permanently green.
Using these mice, the authors observed that developing
pancreas had both green and yellow cells but that later
on in life and in all the models of adult beta-cell
growth/regeneration (pregnancy, partial pancreatec-
tomy, and treating pancreas with alloxan or streptozo-
tocin and duct ligation) yellow cells were not detected
by flow cytometry. Thus, the absence of yellow cells in
their flow cytometry study was interpreted as the ab-
sence of neogenesis from stem cells and supported the
concept of reduplication during regeneration of adult
mouse pancreas. In fact, the group removed all subject-
ivity from their approach by using whole pancreas cell
suspension and assessed the results by the quantitative
approach of flow cytometry. One of the workers in the
field mentioned that their study provided the final nail
in the coffin for beta-cell neogenesis in adult mice pan-
creas [38].We were indeed taken aback by the data generated by
Xiao and colleagues [6] but the group spun their pan-
creas cell suspension at 1,200 revolutions per minute
(rpm) while processing for flow cytometry experiments.
Earlier we reported that VSELs get easily discarded dur-
ing the volume reduction step while processing cord
blood and bone marrow using the standard Ficoll-
hypaque density gradient centrifugation method [39].
The blood stem cells get separated in the ‘buffy coat’,
whereas the VSELs settle down along with red blood
cells and always get discarded [39]. It has taken us a
few years of experience to realize that, because of their
very small size, VSELs do not pellet easily. VSELs exist
in ovary surface epithelium [40] and in order to enrich
them, surface epithelium of a large number of sheep
ovaries was scraped almost four times a week for al-
most 2 months and attempts were made to pellet down
the VSELs by spinning at 1,200 rpm. After a long strug-
gle, we found the VSELs in the supernatant and suc-
cessfully pelleted them by increasing the speed from
1,200 rpm to 1,000G. Now we regularly spin at 1,000G
to enrich VSELs for making smears and at 3,000G for
putting in TRIZOL for RNA extraction. VSELs are truly
the ‘missed pearls’ as described by Mariusz Ratajczak’s
group in various adult mouse tissues, including pan-
creas [41].
VSELs do exist in the pancreas and we are intrigued
by the fact that similar confusion exists in the field of
ovarian biology. Similar to Xiao and colleagues [6], Lei
and Spradling [42] used the lineage-tracing approach
and concluded that adult mouse ovaries lack stem
cells. They proposed that primordial follicle pool gen-
erated during fetal life is sufficient to sustain oogenesis
and that there is no renewal of oocytes during adult
life. But we discussed the technical caveat in their
study and have shown that VSELs are present in adult
mouse ovaries [43]. To conclude, it is apparent that
technology can never overtake biology and Mother
Nature always has more force than the wisdom of the
humans. Although not in the strict sense of lineage
tracing, we have data to demonstrate lineage derivation
of progenitors from the VSELs. A careful examination
of our published results in testis [44], ovary [40], and
pancreas [3] shows how pluripotent VSELs with nu-
clear Oct-4 give rise to tissue-committed progenitors
with cytoplasmic Oct-4. Evidently, the differentiated
tissue-specific progenitors (where nuclear Oct-4 is no
longer required to maintain a pluripotent state) ex-
press cytoplasmic Oct-4, which is eventually lost as the
cells differentiate further. There are three more fronts
in favor of VSEL biology in pancreas: (i) Oct-4+ cells in
human pancreas, (ii) effect of aging on pancreatic biol-
ogy, and (iii) embryonic markers expressed in pancre-
atic cancer.
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Oct-4+ cells (of two distinct sizes) have been reported in
human pancreas, although they were not called VSELs.
Zhao and colleagues [45] detected stem cell markers
Oct-4, SOX-2, and CD34 in islet-enriched fractions of all
25 adult human pancreases, and there were no signifi-
cant differences between endocrine and exocrine cell
fractions. Immunohistochemical staining for Oct-4,
SOX-2, CD133, CD34, CK19, insulin, and nestin on
human pancreas sections showed that the majority of
Oct-4+ cells were found in the walls of small ducts.
Similar localizations were observed for SOX-2+ cells.
The majority of SOX-2+ cells were found to co-express
Oct-4 proteins, but not vice versa. The majority of
Oct-4+ cells had cytosolic staining, whereas a small
percentage (approximately 1.6%) of cells showed nu-
clear positivity. White and colleagues [46] found nu-
clear co-expression of pluripotent markers Oct-4/
SOX-2/NANOG in proliferative ‘islet survivor cells’
and also in adult human pancreas as well as an islet
fraction sample by reverse transcription-polymerase
chain reaction. Various techniques like confocal mi-
croscopy, flow cytometry, and Western blotting were
used to confirm the results. These cells are very small
(1.5 to 3 μm), resembling VSELs. Expression of Oct-4
in human pancreas-derived primary cell cultures has
been reported by other groups also [46,47]. These re-
sults in human pancreas, describing the presence of
smaller cells with nuclear Oct-4 and slightly bigger
cells with cytoplasmic Oct-4, correlate well with our
findings in mice that VSELs have nuclear Oct-4 whereas
slightly bigger cells express cytoplasmic Oct-4 and PDX-1Self-renew
Give rise to 
VSELs with nuclear OCT-
4 exist in mouse and 
human pancreas
Pancreatic progenitors with 
cytoplasmic OCT-4 and PDX-1
Undergo fur
Are mobilized in response to pancreatectomy 
and involved in regeneration  of adult pancreas
Figure 1 The pivotal role played by very small embryonic-like stem cells in
VSEL, very small embryonic-like stem cell.[3]. Thus, based on these studies, our findings in mice
pancreas become relevant to humans as well.
The presence of Oct-4+ cells in the walls of the small
ducts possibly explains the confusing concept put forth
by Bonner-Weir’s group of the involvement of ductal
epithelium in pancreas regeneration. During various
studies performed by Bonner-Weir's group, VSELs were
possibly resulting in a burst of proliferative activity in
the vicinity of ductal epithelium during regeneration,
which was mistakenly interpreted as transdifferentiation
of the epithelial cells into islets.
The effect of aging on pancreatic biology
Age-associated decline in beta-cell function is becoming
apparent and explains the risk for diabetes with ad-
vanced age [48]. The majority of patients with type 2
diabetes mellitus (T2DM) are more than 40 to 50 years
old [49]. Similarly, Paulson and colleagues [50] showed
that the presence of gestational diabetes is increased in
mothers with advanced age. Also, islets isolated from
aged donors result in poor transplantation outcomes
compared with young donors [51]. Kushner [48] put
forth three alternative hypotheses: extended cell cycle
length, fewer aged beta cells entering the cell cycle, or
their limited numbers after puberty may be responsible
for age-related decline. But then why does the beta-cell
mass increase with obesity? As reproductive biologists,
we are tempted to compare pancreas and ovarian biol-
ogy. It has been proposed that menopause occurs be-
cause with advanced age the somatic microenvironment
‘niche’ is unable to support stem cell function [26].
Similarly, aged pancreas will house VSELs but they arether proliferation and differentiation 
Differentiate into islets 
and acinar cells to 
maintain homeostasis 
Unlimited proliferation of VSELs may result in cancer
Type 2 Diabetes Mellitus may arise due to age-
related compromise of somatic niche of pancreatic 
VSELs 
pancreas biology. OCT-4, octamer-binding transcription factor 4;
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mised niche and this may explain the increased inci-
dence of T2DM with increased age.
Embryonic markers expressed in pancreatic cancer
Herreros-Villanueva and colleagues [52] have reported
the aberrant presence of key ESC-specific markers like
Oct-4, Nanog, and SOX-2 in cases of pancreatic ductal
cell carcinoma. Similarly, Lu and colleagues [53] showed
that knockdown of Oct-4 and Nanog expression inhibits
the stemness of pancreatic cancer cells. Earlier, Wen and
colleagues [54] reported expression of Oct-4 and Nanog
with early stages of pancreatic carcinogenesis. All of
these reports support the possibility that pluripotent
VSELs, which express Oct-4, Nanog, SOX-2, Sca-1
(mice), and CD133 (humans), could be the ‘embryonic
remnants’ or cancer-initiating cells in adult organs, in-
cluding pancreas [15]. Starzyńska and colleagues [55] re-
ported intensified trafficking of LIN−/CD45−/CD133+
VSELs and CD45−/CD105+/STRO1+ mesenchymal cells
in patients with pancreatic cancer. Similarly, we demon-
strated that VSELs are implicated during cancer initi-
ation in various reproductive organs after neonatal
endocrine disruption [27]. Similar to the concept that
ovarian cancer may arise due to uncontrolled prolifera-
tion of VSELs because of a compromised niche [26], it is
likely that the pancreas stem cell niche gets altered in a
manner that is unable to keep the VSELs quiescent and
rather they undergo uncontrolled proliferation and
hence cancer (Figure 1). These rapidly dividing cancer
cells will express Oct-4, which is reported in pancreatic
cancer tissue by various groups as discussed above.
Besides VSELs, mesenchymal stem cells (MSCs) have
been reported in the pancreas by various groups, and at-
tempts are being made to treat type 1 diabetes and can-
cer with MSCs. This is a huge topic in itself and beyond
the scope of the present review. But we believe that
MSCs are actually the niche providing stromal cells, ex-
press cytoplasmic Oct-4, and are derived from the
VSELs [56,57]. We recently restored spermatogenesis
from endogenous VSELs (which survived in chemoab-
lated mouse testis) by transplanting MSCs which pro-
vided a healthy niche [58] and allowed surviving VSELs
to undergo differentiation into sperm.
Conclusions
We have explained technical reasons why VSELs have
eluded the scientific community so far and also dis-
cussed the potential role of VSELs during normal pan-
creas biology, regeneration, aging, and cancer (Figure 1).
VSELs exist in human pancreas also. Age-related
changes in the somatic microenvironment result in the
decline of beta-cell regeneration and hence increased in-
cidence of T2DM. The uncontrolled proliferation ofpluripotent VSELs possibly results in cancer. Thus, our
article provides an altogether new perspective and di-
mension to the field of pancreas biology in both mice
and humans and opens up newer areas for research.
We earnestly request that others in the field carefully
review their protocols for studying stem cells by flow cy-
tometry. The use of a speed of 1,200 rpm to spin down
cells, while processing them for various experiments,
may explain the inability to detect VSELs in mouse bone
marrow similar to while processing pancreatic cells
[6,10]. Hopefully, as an outcome of this article, the con-
troversy surrounding VSELs will settle and further stud-
ies will be undertaken to exploit their potential to
regenerate the diabetic pancreas. We are intrigued by the
potential of VSELs to regenerate both the islets and acinar
cells in adult mouse pancreas compared with embryonic
or induced pluripotent stem cells which, as reviewed re-
cently, tend to give rise to fetal counterparts [1,59].
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